Low‐dose desoxycorticosterone pivalate treatment of hypoadrenocorticism in dogs: A randomized controlled clinical trial

BACKGROUND: Desoxycorticosterone pivalate (DOCP) is a commonly used mineralocorticoid replacement for dogs with primary hypoadrenocorticism (HA), but manufacturer‐recommended dosing protocols can be cost‐prohibitive. Recent reports also have raised concerns that label dose protocols could be excessi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Vet Intern Med
Autori principali: Vincent, Alysha M., Okonkowski, Linda K., Brudvig, Jean M., Refsal, Kent R., Berghoff, Nora, Olivier, N. Bari, Langlois, Daniel K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Inc. 2021
Soggetti:
SMALL ANIMAL
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8295656/
https://ncbi.nlm.nih.gov/pubmed/34114259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.16195
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi